Smart Inhalers Market By Type (Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers), By Application (COPD, Asthma and Others) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

The smart inhalers market is set to reach from US$ 1,006.6 Mn in 2017 to US$ 3,674.6 Mn by 2026 at a compound annual growth rate (CAGR) of 15.7% during the forecast period from 2018 to 2026. Smart inhalers are mounted on respiratory inhalers and nebulizers and provides its services via wireless smart apps and cloud computing systems. They are useful in adjusting the inhaled dose and also reminds the patients regularly by sending alert messages to take medication on time, thereby optimally enhancing patient adherence and compliance with inhaled medications prescribed for chronic respiratory diseases such as COPD and asthma.

Market Synopsis 

Get a sample copy for more information

"Excellent drug pharmacokinetic/pharmacodynamic modeling and patient compliance drive the metered dose inhalers market growth"

Metered dose inhalers (MDIs) are supremely reigning the type segment for smart inhalers market. The inherent features associated with its formulation are excellent drug PK/PD profile and enhanced patient compliance. Availability of sensors to monitor and adjust the dose of API and increasing popularity in geriatric patients further fortify MDIs market growth. Dry powder inhalers will register excellent growth in the near future on account of rising public awareness related to the drug irritation and adverse effects caused by propellants employed in MDIs. Nebulizers are widely employed in infants due to high degree of safety and efficacy associated with the drug delivery system.

Get a sample copy for more information

"Rampant growth in tobacco smoking population and increasing air pollution drive the COPD market growth"

In the present scenario chronic obstructive pulmonary disorders are leading the application segment for smart inhalers market. Rampant growth in tobacco smoking population and increasing air pollution together fortify the market growth of COPD. As per the statistics provided by World Health Organization (WHO) in 2016, approximately 251 million cases were reported worldwide suffering with COPD. The prevalence rate is higher in middle and low income countries owing to high exposure to occupational dust and fumes. There is no permanent cure for COPD, but effective medication with smart inhalers can improve the quality of life and lower the risk of death. Asthma holds the second position in the application segment for smart inhalers market. There are several triggering factors for asthma such as exposure to allergens, dust, smoking, allergic rhinitis and hereditary in most cases. Instant medication it the form of inhalers and nebulizers provide quick symptomatic relief in patients having asthma episodes.

Get a sample copy for more information

"Rising prevalence of pulmonary disorders and increasing public health awareness drive the market growth in North America"

In the current scenario North America dominates the regional segment for smart inhalers market. It has a market share of 38% on account of major factors such as rising prevalence of chronic disease and rising public health awareness. According to the statistics provided by Center for Disease Control and Prevention (CDC), the age adjusted prevalence rate of COPD in the United States is 6.0%, with high prevalence reported in the female population. Domicile of key players such as 3M Healthcare, Propeller Health, Cohero Health etc., drive the market growth in North America region. Europe represents a market share of 29% and is currently the second largest regional segment for smart inhalers market. Strategic collaboration between government healthcare agencies and pharmaceutical giants and increasing number of children suffering with asthma propel the market growth in Europe. Asia Pacific represents 20% share in smart inhalers market. It will grow at a significant pace during the forecast period from 2018 to 2026 owing to the increasing geriatric population suffering with respiratory illness and emergence of local IT healthcare companies competing with major players to develop smart sensors and applications for respiratory inhalers.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market segmentation comprises of by type, application and geography.

Companies in collaboration with pharmaceutical key players engaged in the development of smart inhalers are Amiko, Adherium Limited, Cohero Health, 3M Healthcare, Opko Health, Inc., Propeller Health, Philips Respironics, Sensirion AG, Teva Pharmaceutical Industries Limited and Vectura Group, Plc.

Key questions answered in this report

• What are the latest strategic collaboration and merger taking place between IT healthcare providers and pharmaceutical giants providing respiratory inhalers?
• What is the DRO’s associated with smart inhalers market?
• What is the global prevalence rate of COPD and how will smart inhalers impact its treatment?
• What will be the factors responsible for the significant growth of dry powder inhalers in the near future?
• What are the primary features responsible for the supremacy of North America in smart inhalers market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global SI Market Portraiture
2.2. Global SI Market, by Type, 2017 (US$ Mn)
2.3. Global SI Market, by Application, 2017 (US$ Mn)
2.4. Global SI Market, by Geography, 2017 (US$ Mn)

Chapter 3. Smart Inhalers (SI) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global SI Market, by Key Players, 2017

Chapter 4. Global Smart Inhalers (SI) Market, by Type
4.1. Overview
4.2. Metered Dose Inhalers
4.3. Dry Powder Inhalers
4.4. Nebulizers

Chapter 5. Global Smart Inhalers (SI) Market, by Application
5.1. Overview
5.2. Chronic Obstructive Pulmonary Disease (COPD)
5.3. Asthma
5.4. Others

Chapter 6. Global Smart Inhalers (SI) Market, by Geography
6.1. Overview
6.2. North America SI Market Analysis, 2016 – 2026
6.2.1. North America SI Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America SI Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America SI Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe SI Market Analysis, 2016 – 2026
6.3.1. Europe SI Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe SI Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific SI Market Analysis, 2016 – 2026
6.4.1. Asia Pacific SI Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific SI Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America SI Market Analysis, 2016 – 2026
6.5.1. Latin America SI Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America SI Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa SI Market Analysis, 2016 – 2026
6.6.1. MEA SI Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA SI Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Amiko
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Adherium Limited
7.3. Cohero Health
7.4. 3M Healthcare
7.5. Opko Health, Inc.
7.6. Propeller Health
7.7. Philips Respironics
7.8. Sensirion AG
7.9. Teva Pharmaceutical Industries Ltd.
7.10. Vectura Group, Plc.

FIG. 1 Smart Inhalers (SI) Market: Research Methodology
FIG. 2 SI Market Segmentation
FIG. 3 Global SI Market, by Type, 2017 (US$ Mn)
FIG. 4 Global SI Market, by Application, 2017 (US$ Mn)
FIG. 5 Global SI Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global SI Market, by Key Players, 2017
FIG. 8 Global Metered Dose SI Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Dry Powder SI Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nebulizers SI Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global COPD Market for Smart Inhalers, 2016 – 2026 (US$ Mn)
FIG. 12 Global Asthma Market for Smart Inhalers, 2016 – 2026 (US$ Mn)
FIG. 13 Global Other Applications Market for Smart Inhalers, 2016 – 2026 (US$ Mn)
FIG. 14 U.S. SI Market, 2016 – 2026 (US$ Mn)
FIG. 15 Canada SI Market, 2016 – 2026 (US$ Mn)
FIG. 16 U.K. SI Market, 2016 – 2026 (US$ Mn)
FIG. 17 Germany SI Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest of Europe SI Market, 2016 – 2026 (US$ Mn)
FIG. 19 China SI Market, 2016 – 2026 (US$ Mn)
FIG. 20 Japan SI Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Asia Pacific SI Market, 2016 – 2026 (US$ Mn)
FIG. 22 Brazil SI Market, 2016 – 2026 (US$ Mn)
FIG. 23 Mexico SI Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest of Latin America SI Market, 2016 – 2026 (US$ Mn)
FIG. 25 GCC SI Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest of MEA SI Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Smart Inhalers (SI) Market Portraiture
TABLE 2 Global SI Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global SI Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global SI Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America SI Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America SI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America SI Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe SI Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe SI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific SI Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific SI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America SI Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America SI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa SI Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa SI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Amiko: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Adherium Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Cohero Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 3M Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Opko Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Propeller Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Philips Respironics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Sensirion AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vectura Group, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)